Swisher Daniel N Jr sold 1,500 shares of CORCEPT THERAPEUTICS INC at $74.07 for −$111k on Nov 10, 2026

Sell
Form 4 code S. Open-market or private sale of a non-derivative or derivative security.
Director
DIR
Filed Nov 13, 2026

Facts from the filing

Form 4 · Non-derivative, table I
Disclosed value
−$111,105Shares × reported price
Shares traded
1,500Common Stock
Price per share
$74.07Reported price. Read footnotes for ranges.
% of reported position traded
100%This security and ownership context
Holdings after
0Direct
Trade date
Nov 10, 2026Sell
Filed
Nov 13, 2026, 4:30 PM ET3-day reporting delay
Accession
0001193125-26-460765Code S · Transaction 400748
How reported position traded is calculated

Shares sold ÷ (holdings after + shares sold). Estimated position before: 1,500 shares.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

Trade dateActivitySharesPriceValueDetails
Nov 10, 2026Option exercise1,100$14.08$15,488Trade 400746
Nov 10, 2026Option exercise400$10.50$4,200Trade 400747
Nov 10, 2026Option exercise1,100$0.00$0Trade 400749
Nov 10, 2026Option exercise400$0.00$0Trade 400750
5 transaction rows in this filing. Joint filers share the same rows.

CORT price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
CORT · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.

Return windows are pending. The first 7-day window is eligible on Nov 20, 2026. Values appear when the daily price refresh supplies a valid close for that window. Weekends, market holidays and missing prices can delay updates.

Pre-filing1mo ago +66%1w ago +12%1d ago +2.9%
Returns since7d30d90d180d1y

Footnotes in full

F1: The transaction was made pursuant to a 10b5-1 plan adopted by the Reporting Person on August 3, 2026 in effect at the time of this transaction. F2: Fully exercisable. F3: The Reporting Person previously transferred 12,500 shares underlying the stock option to his ex-spouse. The Reporting Person no longer reports as beneficially owned any securities owned by his ex-spouse.